Medical research

Potential COVID-19 treatment identified

A collaboration among scientists from UCLA and other universities in California, Delaware and Germany, as well as a German pharmaceutical company, has singled out a compound that shows promise for treating SARS-CoV-2, the ...

Oncology & Cancer

Lung cancer resistance: the key is glucose

Cancers are not only made of tumor cells. In fact, as they grow, they develop an entire cellular ecosystem within and around them. This "tumor microenvironment" is made up of multiple cell types, including cells of the immune ...

Medical research

Enzymatic danse macabre of lung cancer

A chromatin-regulating enzyme has been shown by in-depth interdisciplinary investigations to be a key driver of a common type of lung cancer. Drugs that target the enzyme could improve treatment and survival rates for this ...

Oncology & Cancer

Scientists identify a potential target to treat lung cancer

In cancer, personalized medicine takes advantage of the unique genetic changes in an individual tumor to find its vulnerabilities and fight it. Many tumors have a higher number of mutations due to a antiviral defense mechanism, ...

Medications

Tislelizumab plus chemo slows advanced squamous NSCLC

(HealthDay)—For patients with advanced squamous non-small cell lung cancer (sq- NSCLC), adding tislelizumab in combination with chemotherapy is associated with improved progression-free survival (PFS), according to a study ...

page 1 from 2